Boston Scientific (BSX) Change in Inventory (2020 - 2026)

Boston Scientific (BSX) has 7 years of Change in Inventory data on file, last reported at $177.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory rose 62.39% year-over-year to $177.0 million; the trailing twelve-month figure through Mar 2026 stood at $256.0 million (up 20.19% YoY), and the FY2025 full-year result was $188.0 million, down 17.54% from the prior year.
• Change in Inventory improved to $177.0 million in Q1 2026, from $50.0 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $214.0 million in Q2 2023 to a low of -$65.0 million in Q2 2025.
• A 5-year average of $92.6 million and a median of $95.0 million in 2022 frame the typical range for Change in Inventory.
• Across the five-year window, Change in Inventory soared 580.0% in 2022 and slumped 177.97% in 2024, its largest moves.
• Tracing BSX's Change in Inventory over 5 years: stood at $46.0 million in 2022, then rose by 28.26% to $59.0 million in 2023, then slumped by 177.97% to -$46.0 million in 2024, then jumped by 208.7% to $50.0 million in 2025, then jumped by 254.0% to $177.0 million in 2026.
• Business Quant data shows BSX's Change in Inventory at $177.0 million in Q1 2026, $50.0 million in Q4 2025, and $94.0 million in Q3 2025.